As of 2025-09-15, the Relative Valuation of FibroGen Inc (FGEN) is (6.78) USD. This relative valuation is based on P/E multiples. With the latest stock price at 12.03 USD, the upside of FibroGen Inc based on Relative Valuation is -156.3%.
The range of the Relative Valuation is (5.44) - (7.74) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 10.6x - 15.1x | 13.3x |
| Forward P/E multiples | 5.9x - 16.6x | 13.2x |
| Fair Price | (5.44) - (7.74) | (6.78) |
| Upside | -145.2% - -164.4% | -156.3% |
| Date | P/E |
| 2025-09-11 | -24.31 |
| 2025-09-10 | -22.51 |
| 2025-09-09 | -22.45 |
| 2025-09-08 | -21.82 |
| 2025-09-05 | -23.66 |
| 2025-09-04 | -22.12 |
| 2025-09-03 | -23.39 |
| 2025-09-02 | -23.82 |
| 2025-08-29 | -23.13 |
| 2025-08-28 | -21.76 |
| 2025-08-27 | -20.49 |
| 2025-08-26 | -20.24 |
| 2025-08-25 | -20.79 |
| 2025-08-22 | -21.86 |
| 2025-08-21 | -21.69 |
| 2025-08-20 | -20.77 |
| 2025-08-19 | -20.65 |
| 2025-08-18 | -22.10 |
| 2025-08-15 | -18.57 |
| 2025-08-14 | -18.54 |
| 2025-08-13 | -19.32 |
| 2025-08-12 | -18.09 |
| 2025-08-11 | -16.37 |
| 2025-08-08 | -17.03 |
| 2025-08-07 | -15.53 |
| 2025-08-06 | -13.89 |
| 2025-08-05 | -13.51 |
| 2025-08-04 | -13.55 |
| 2025-08-01 | -13.47 |
| 2025-07-31 | -13.53 |
| 2025-07-30 | -13.75 |
| 2025-07-29 | -14.04 |
| 2025-07-28 | -14.10 |
| 2025-07-25 | -14.57 |
| 2025-07-24 | -14.14 |
| 2025-07-23 | -14.76 |
| 2025-07-22 | -15.08 |
| 2025-07-21 | -14.78 |
| 2025-07-18 | -14.96 |
| 2025-07-17 | -15.78 |
| 2025-07-16 | -14.71 |
| 2025-07-15 | -14.31 |
| 2025-07-14 | -15.04 |
| 2025-07-11 | -13.98 |
| 2025-07-10 | -14.37 |
| 2025-07-09 | -12.10 |
| 2025-07-08 | -10.99 |
| 2025-07-07 | -10.50 |
| 2025-07-03 | -10.97 |
| 2025-07-02 | -10.27 |